These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Lantz CS; Boesiger J; Song CH; Mach N; Kobayashi T; Mulligan RC; Nawa Y; Dranoff G; Galli SJ Nature; 1998 Mar; 392(6671):90-3. PubMed ID: 9510253 [TBL] [Abstract][Full Text] [Related]
24. cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation. Francis ML; Okazaki I; Moss J; Kurosky A; Pecanha LM; Mond JJ J Immunol; 1995 May; 154(10):4956-64. PubMed ID: 7730606 [TBL] [Abstract][Full Text] [Related]
25. Cholera toxin induces tumor necrosis factor alpha production in human monocytes. Yan Z; Yang DC; Jett M Mol Cell Biol Res Commun; 1999 Aug; 2(2):124-30. PubMed ID: 10542136 [TBL] [Abstract][Full Text] [Related]
26. [Interleukin 3 (IL-3)]. Kusumi A; Kumagai K Gan To Kagaku Ryoho; 1994 May; 21(6):915-25. PubMed ID: 8185355 [TBL] [Abstract][Full Text] [Related]
27. Murine KIT+ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation. Lantz CS; Huff TF J Immunol; 1995 Jan; 154(1):355-62. PubMed ID: 7527815 [TBL] [Abstract][Full Text] [Related]
28. [The role of interleukin-3 (IL-3) in hemopoiesis]. Suda T Rinsho Ketsueki; 1986 Jul; 27(7):1166-71. PubMed ID: 3491228 [No Abstract] [Full Text] [Related]
29. Differential sensitivity of normal and chemically transformed epithelial cells to cholera toxin. Niles RM; Loewy B; Krah D Cancer Res; 1981 Oct; 41(10):4075-9. PubMed ID: 6269734 [TBL] [Abstract][Full Text] [Related]
30. Intracellular cAMP regulates the cytotoxicity of recombinant tumor necrosis factor for L cells in vitro. Chun M; Hoffmann MK Lymphokine Res; 1987; 6(3):161-7. PubMed ID: 3041126 [TBL] [Abstract][Full Text] [Related]
31. Development and differentiation of mast cells and basophils. Kitamura Y; Miyoshi I Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1251-9. PubMed ID: 751405 [No Abstract] [Full Text] [Related]
32. Growth inhibitors in haemopoiesis and leukaemogenesis. Graham GJ Baillieres Clin Haematol; 1997 Sep; 10(3):539-59. PubMed ID: 9421615 [TBL] [Abstract][Full Text] [Related]
33. Haemopoietic stem cells and basophils. Drummond R Med Hypotheses; 1994 Sep; 43(3):160-2. PubMed ID: 7815970 [TBL] [Abstract][Full Text] [Related]
35. Regulation of hemopoietic cell development by interleukins 4, 5 and 6. Rennick D; Hudak S; Yang G; Jackson J Immunol Res; 1989; 8(3):215-25. PubMed ID: 2664035 [No Abstract] [Full Text] [Related]
36. A model of hematopoietic stem cell proliferation under the influence of a chemotherapeutic agent in combination with a hematopoietic inducing agent. Mouser CL; Antoniou ES; Tadros J; Vassiliou EK Theor Biol Med Model; 2014 Jan; 11():4. PubMed ID: 24438084 [TBL] [Abstract][Full Text] [Related]
37. Immunological regulation of hematopoietic/lymphoid stem cell differentiation by interleukin 3. Ihle JN; Weinstein Y Adv Immunol; 1986; 39():1-50. PubMed ID: 3538818 [No Abstract] [Full Text] [Related]
39. [Experimental studies on interleukin-3]. Liu YH; Qian YK Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):17-21. PubMed ID: 2672306 [No Abstract] [Full Text] [Related]
40. Cholera toxin as an intracellular cAMP-inducing agent in the regulation of haemopoietic cell development and differentiation. Lanotte M; Hermouet S Ann Inst Pasteur Immunol; 1986; 137D(2):201-13. PubMed ID: 3026419 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]